Literature DB >> 23558460

Andrimid production at low temperature by a psychrotolerant Serratia proteamaculans strain.

Leandro A Sánchez1, Manuel González Sierra, Faustino Siñeriz, Osvaldo Delgado.   

Abstract

Andrimid, a known non-ribosomal pseudo-peptide antibiotic, was isolated from a psychrotolerant Serratia proteamaculans strain. The antibiotic peptide was produced at low temperature (8 °C) in a 7.5 l BIOFLO 101 bioreactor under batch culture mode. Andrimid activity from S. proteamaculans culture was only detected at 25 °C and below and potent antibacterial activity was revealed against both, pathogenic and non-pathogenic bacteria. Minimal inhibitory concentration values determined by microdilution experiments varied in the range between 0.01 and 0.78 μg/ml. Antimicrobial purification and structure elucidation were carried out by LC-MS/MS and ¹H/¹³C NMR approaches. The effects on the ultrastructure of sensitive Escherichia coli 35,218 cells were observed by transmission electron microscopy at different inhibition stages. This work demonstrated the significance of bioprospection from cold environments through the screening of microorganisms with ability to produce cold-active biomolecules of biotechnological interest. S. proteamaculans 136 was revealed as a novel microbial source for andrimid production at low temperatures, showing biotechnological potential to be applied in cryopreservation, food or cosmetic industries against pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558460     DOI: 10.1007/s11274-013-1338-9

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  35 in total

1.  Do we need new antibiotics? The search for new targets and new compounds.

Authors:  Jaroslav Spížek; Jitka Novotná; Tomáš Rezanka; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-11-18       Impact factor: 3.346

Review 2.  Extreme environments as a resource for microorganisms and novel biocatalysts.

Authors:  Garabed Antranikian; Constantinos E Vorgias; Costanzo Bertoldo
Journal:  Adv Biochem Eng Biotechnol       Date:  2005       Impact factor: 2.635

Review 3.  Serratia marcescens: historical perspective and clinical review.

Authors:  V L Yu
Journal:  N Engl J Med       Date:  1979-04-19       Impact factor: 91.245

4.  Antagonistic interactions among marine bacteria impede the proliferation of Vibrio cholerae.

Authors:  Richard A Long; David C Rowley; Eric Zamora; Jiayuan Liu; Douglas H Bartlett; Farooq Azam
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

5.  Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action.

Authors:  Jens Pohlmann; Thomas Lampe; Mitsuyuki Shimada; Peter G Nell; Josef Pernerstorfer; Niels Svenstrup; Nina A Brunner; Guido Schiffer; Christoph Freiberg
Journal:  Bioorg Med Chem Lett       Date:  2005-02-15       Impact factor: 2.823

6.  Characterization of a bacteriocin, Thermophilin 1277, produced by Streptococcus thermophilus SBT1277.

Authors:  T Kabuki; H Uenishi; M Watanabe; Y Seto; H Nakajima
Journal:  J Appl Microbiol       Date:  2007-04       Impact factor: 3.772

7.  Production, purification and characterization of serraticin A, a novel cold-active antimicrobial produced by Serratia proteamaculans 136.

Authors:  L A Sánchez; M Hedström; M A Delgado; O D Delgado
Journal:  J Appl Microbiol       Date:  2010-09       Impact factor: 3.772

Review 8.  Antibiotics from microbes: converging to kill.

Authors:  Michael A Fischbach
Journal:  Curr Opin Microbiol       Date:  2009-08-18       Impact factor: 7.934

9.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.

Authors:  Matthew T G Holden; Edward J Feil; Jodi A Lindsay; Sharon J Peacock; Nicholas P J Day; Mark C Enright; Tim J Foster; Catrin E Moore; Laurence Hurst; Rebecca Atkin; Andrew Barron; Nathalie Bason; Stephen D Bentley; Carol Chillingworth; Tracey Chillingworth; Carol Churcher; Louise Clark; Craig Corton; Ann Cronin; Jon Doggett; Linda Dowd; Theresa Feltwell; Zahra Hance; Barbara Harris; Heidi Hauser; Simon Holroyd; Kay Jagels; Keith D James; Nicola Lennard; Alexandra Line; Rebecca Mayes; Sharon Moule; Karen Mungall; Douglas Ormond; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Sarah Sharp; Mark Simmonds; Kim Stevens; Sally Whitehead; Bart G Barrell; Brian G Spratt; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-22       Impact factor: 11.205

Review 10.  Production of bioactive secondary metabolites by marine vibrionaceae.

Authors:  Maria Mansson; Lone Gram; Thomas O Larsen
Journal:  Mar Drugs       Date:  2011-08-25       Impact factor: 6.085

View more
  3 in total

1.  Biosynthesis of the acetyl-CoA carboxylase-inhibiting antibiotic, andrimid in Serratia is regulated by Hfq and the LysR-type transcriptional regulator, AdmX.

Authors:  Miguel A Matilla; Veronika Nogellova; Bertrand Morel; Tino Krell; George P C Salmond
Journal:  Environ Microbiol       Date:  2016-05-25       Impact factor: 5.491

2.  The Integration of Genome Mining, Comparative Genomics, and Functional Genetics for Biosynthetic Gene Cluster Identification.

Authors:  Ashley N Williams; Naveen Sorout; Alexander J Cameron; John Stavrinides
Journal:  Front Genet       Date:  2020-12-03       Impact factor: 4.599

Review 3.  Extending the "One Strain Many Compounds" (OSMAC) Principle to Marine Microorganisms.

Authors:  Stefano Romano; Stephen A Jackson; Sloane Patry; Alan D W Dobson
Journal:  Mar Drugs       Date:  2018-07-23       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.